Article info
Editorial
Cost–effectiveness of treatments for diabetic macular oedema: should we pay more attention to the appraisal and reporting of economic evaluations?
- Correspondence to Professor Gianni Virgili, Department of Ophthalmology, Careggi Hospital Eye Clinic, University of Florence, V.le Morgagni 85, Florence 50134, Italy; gianni.virgili{at}unifi.it
Citation
Cost–effectiveness of treatments for diabetic macular oedema: should we pay more attention to the appraisal and reporting of economic evaluations?
Publication history
- First published June 20, 2013.
Online issue publication
March 22, 2016
Article Versions
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions